サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1266692

幹細胞アッセイの世界市場：動向、機会、競合分析（2023年～2028年）

Stem Cell Assay Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

幹細胞アッセイの世界市場：動向、機会、競合分析（2023年～2028年）
出版日: 2023年04月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の幹細胞アッセイの市場規模は、2023年から2028年までの間に19.1%のCAGRで成長し、2028年までに推定40億米ドルに達すると予想されています。市場の成長を後押しする主な要因には、幹細胞の治療能力に対する意識の高まり、現在の幹細胞培養技術の受容率の上昇、がんや心血管疾患の症例の増加などが挙げられます。

当レポートでは、世界の幹細胞アッセイ市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・課題、アッセイタイプ別・細胞タイプ別・製品・サービス別・用途別・最終用途産業別・地域別などの分析、さらに競合分析などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の幹細胞アッセイ市場：市場力学

  • イントロダクション、背景、および分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析（2017年～2028年）

  • マクロ経済の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界の幹細胞アッセイ市場の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界の幹細胞アッセイ市場：アッセイタイプ別
    • 生存能力／細胞毒性
    • 分離・精製
    • 細胞同定
    • 増殖
    • 分化
    • 機能
    • アポトーシス
    • その他
  • 世界の幹細胞アッセイ市場：細胞タイプ別
    • 成体幹細胞
    • 間葉系幹細胞
    • 人工多能性幹細胞
    • 造血幹細胞
    • 臍帯幹細胞
    • 神経幹細胞
    • ヒト胚性幹細胞
  • 世界の幹細胞アッセイ市場：製品・サービス別
    • 機器
    • フローサイトメーター
    • マイクロ電極アレイ
    • 細胞イメージング・分析システム
    • 自動細胞カウンター
    • キット
    • サービス
  • 世界の幹細胞アッセイ市場：用途別
    • 再生医療・治療開発
    • 整形外科、筋骨格、脊椎
    • 皮膚科
    • 心血管
    • 中枢神経系
    • 腫瘍学
    • 糖尿病
    • 創薬・開発
  • 世界の幹細胞アッセイ市場：最終用途産業別
    • バイオ医薬品・バイオテクノロジー企業
    • 学術・研究機関

第4章 市場動向と予測分析：地域別（2017年～2028年）

  • 地域別の幹細胞アッセイ市場
  • 北米の幹細胞アッセイ市場
    • 北米の幹細胞アッセイ市場、アッセイタイプ別：生存能力／細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス、その他
    • 北米の幹細胞アッセイ市場、最終用途産業別：バイオ医薬品・バイオテクノロジー企業、学術・研究機関
  • 欧州の幹細胞アッセイ市場
    • 欧州の幹細胞アッセイ市場、アッセイタイプ別：生存能力／細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス、その他
    • 欧州の幹細胞アッセイ市場、最終用途産業別：バイオ医薬品・バイオテクノロジー企業、学術・研究機関
  • アジア太平洋の幹細胞アッセイ市場
    • アジア太平洋の幹細胞アッセイ市場、アッセイタイプ別：生存能力／細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス、その他
    • アジア太平洋の幹細胞アッセイ市場、最終用途産業別：バイオ医薬品・バイオテクノロジー企業、学術・研究機関
  • その他の地域の幹細胞アッセイ市場
    • その他の地域の幹細胞アッセイ市場、アッセイタイプ別：生存能力／細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス、その他
    • その他の地域の幹細胞アッセイ市場、最終用途産業別：バイオ医薬品・バイオテクノロジー企業、学術・研究機関

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界の幹細胞アッセイ市場の成長機会：アッセイタイプ別
    • 世界の幹細胞アッセイ市場の成長機会：細胞タイプ別
    • 世界の幹細胞アッセイ市場の成長機会：製品・サービス別
    • 世界の幹細胞アッセイ市場の成長機会：用途別
    • 世界の幹細胞アッセイ市場の成長機会：最終用途産業別
    • 世界の幹細胞アッセイ市場の成長機会：地域別
  • 世界の幹細胞アッセイ市場における新たな動向
  • 戦略分析
    • 新製品の開発
    • 世界の幹細胞アッセイ市場のキャパシティ拡大
    • 世界の幹細胞アッセイ市場における合併、買収、合弁事業
    • 認定とライセンシング

第7章 主要企業の企業プロファイル

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories
目次

Stem Cell Assay Market Trends and Forecast

The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Stem Cell Assay Market by Segment

The study includes trends and forecast for the global stem cell assay market by type, cell type, product & service, application, end use industry, and region, as follows:

Stem Cell Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Viability or Cytotoxicity
  • Isolation and Purification
  • Cell Identification
  • Proliferation
  • Differentiation
  • Function
  • Apoptosis
  • Others

Stem Cell Assay Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Adult
  • Mesenchymal
  • Induced Pluripotent
  • Hematopoietic
  • Umbilical Cord
  • Neural
  • Human Embryonic

Stem Cell Assay Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Instruments
  • Flow Cytometers
  • Microelectrode Arrays
  • Cell Imaging & Analysis Systems
  • Automated Cell Counters
  • Kits
  • Services

Stem Cell Assay Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Regenerative Medicine & Therapy Development
  • Orthopedic, Musculoskeletal, and Spine Application
  • Dermatology Application
  • Cardiovascular Application
  • CNS Application
  • Oncology Application
  • Diabetes Application
  • Drug Discovery & Development
  • Clinical Research

Stem Cell Assay Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

Stem Cell Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stem Cell Assay Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, stem cell assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell assay companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories

Stem Cell Assay Market Insights

  • Lucintel forecasts that viability/cytotoxicity assay will remain the largest type segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
  • Within this market, the biopharmaceutical & biotechnology companies segment is expected to record the highest growth due to growing prevalence of chronic diseases, an increase in the number of clinical trials, and growing strategic activities along with improvements in healthcare services.
  • North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.

Features of the Stem Cell Assay Market

  • Market Size Estimates: Stem cell assay market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Stem cell assay market size by various segments, such as by type, cell type, product & service, application, end use industry, and region
  • Regional Analysis: Stem cell assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by type, cell type, product & service, application, end use industry, and regions for the stem cell assay market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell assay market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the stem cell assay market size?

Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.

Q2. What is the growth forecast for stem cell assay market?

Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the stem cell assay market?

Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.

Q4. What are the major segments for stem cell assay market?

Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.

Q5. Who are the key stem cell assay companies?

Answer: Some of the key stem cell assay companies are as follows:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories

Q6. Which stem cell assay segment will be the largest in future?

Answer:Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.

Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1.What are some of the most promising, high-growth opportunities for the stem cell assay market by type (viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, apoptosis, and others), cell type (adult, mesenchymal, induced pluripotent, hematopoietic, umbilical cord, neural, human embryonic), product & service (instruments, flow cytometers, microelectrode arrays, cell imaging & analysis systems, automated cell counters, and kits services), application (regenerative medicine & therapy development, orthopedic, musculoskeletal, and spine application, dermatology application, cardiovascular application, CNS application, oncology application, diabetes application, drug discovery & development, and clinical research), end use industry (biopharmaceutical & biotechnology companies and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stem Cell Assay Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Stem Cell Assay Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Stem Cell Assay Market by Assay Type
    • 3.3.1: Viability or Cytotoxicity
    • 3.3.2: Isolation and Purification
    • 3.3.3: Cell Identification
    • 3.3.4: Proliferation
    • 3.3.5: Differentiation
    • 3.3.6: Function
    • 3.3.7: Apoptosis
    • 3.3.8: Others
  • 3.4: Global Stem Cell Assay Market by Cell Type
    • 3.4.1: Adult
    • 3.4.2: Mesenchymal
    • 3.4.3: Induced Pluripotent
    • 3.4.4: Hematopoietic
    • 3.4.5: Umbilical Cord
    • 3.4.6: Neural
    • 3.4.7: Human Embryonic
  • 3.5: Global Stem Cell Assay Market by Product & Service
    • 3.5.1: Instruments
    • 3.5.2: Flow Cytometers
    • 3.5.3: Microelectrode Arrays
    • 3.5.4: Cell Imaging & Analysis Systems
    • 3.5.5: Automated Cell Counters
    • 3.5.6: Kits
    • 3.5.7: Services
  • 3.6: Global Stem Cell Assay Market by Application
    • 3.6.1: Regenerative Medicine & Therapy Development
    • 3.6.2: Orthopedic, Musculoskeletal, and Spine Application
    • 3.6.3: Dermatology Application
    • 3.6.4: Cardiovascular Application
    • 3.6.5: CNS Application
    • 3.6.6: Oncology Application
    • 3.6.7: Diabetes Application
    • 3.6.8: Drug Discovery & Development
  • 3.7: Global Stem Cell Assay Market by End Use Industry
    • 3.7.1: Biopharmaceutical & Biotechnology Companies
    • 3.7.2: Academic & Research Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Stem Cell Assay Market by Region
  • 4.2: North American Stem Cell Assay Market
    • 4.2.1: North American Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.2.2: North American Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.3: European Stem Cell Assay Market
    • 4.3.1: European Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.3.2: European Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.4: APAC Stem Cell Assay Market
    • 4.4.1: APAC Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.4.2: APAC Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.5: ROW Stem Cell Assay Market
    • 4.5.1: ROW Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.5.2: ROW Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stem Cell Assay Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global Stem Cell Assay Market by Cell Type
    • 6.1.3: Growth Opportunities for the Global Stem Cell Assay Market by Product & Service
    • 6.1.4: Growth Opportunities for the Global Stem Cell Assay Market by Application
    • 6.1.5: Growth Opportunities for the Global Stem Cell Assay Market by End Use Industry
    • 6.1.6: Growth Opportunities for the Global Stem Cell Assay Market by Region
  • 6.2: Emerging Trends in the Global Stem Cell Assay Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stem Cell Assay Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Assay Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck KGaA
  • 7.3: Danaher
  • 7.4: Becton, Dickinson and Company
  • 7.5: Agilent Technologies
  • 7.6: Bio-Techne Corporation
  • 7.7: Lonza Group
  • 7.8: PerkinElmer
  • 7.9: Cell Biolabs
  • 7.10: Bio-Rad Laboratories